DZS Software Solutions Releases Customer-Focused ClinPlus CTMS Version 2.3


Company News Release

Bound Brook, NJ (October 22, 2015)  DZS Software Solutions, Inc. today announced the release of ClinPlus CTMS version 2.3, a Clinical Trial Management System (CTMS) that includes 70 enhancements, most of which were inspired by customer feedback.

“Because DZS Software Solutions, Inc. is a customer focused company, their requests were given serious consideration and are the driving force behind Version 2.3,” said Bob Borysko, Vice President of Business Development.   “As new clients come online they invariably will have unique requirements they would like to see addressed in the software.  Our software engineers evaluate each request and design solutions that will not only satisfy the client making the request, but also may benefit the entire user base and improve overall marketability. This customer focused design philosophy is the primary reason for our high level of customer satisfaction and accelerating rate of new client adoption.”

Version 2.3 adds the ability to support read-only licenses and every ClinPlus CTMS client will receive five at no additional cost.   Other areas of improvements include:

  • Improved system navigation and administration

  • Enhanced ad-hoc reporting features with additional metrics and standard reports

  • Better manageability of global contact and institution databases

  • More flexible control over role-based security and password recovery options

  • Additional site reimbursement payment approval triggers (procedures, monitoring status, other)

  • Improved site visit scheduling and an enhanced SVR authoring and review process

  • Enhancements to eTMF features

The development process continues toward the next major release for 2016, ClinPlus eClinical 3, which will not only include significant enhancement to CTMS but will also incorporate full EDC capabilities within the eClinical platform. To learn more, contact Bob Borysko at (732) 764-6969.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.